"Retrospective Study to Identify Clinical Factors Related to a High Benefit of Axitinib in mRCC"
NCT03538717
·
clinicaltrials.gov ↗
COMPLETED
Status
157
Enrollment
INDUSTRY
Sponsor class
Conditions
Carcinoma, Renal Cell
Sponsor
Pfizer